These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7852427)

  • 1. Human umbilical vein endothelial cells express high affinity neurotensin receptors coupled to intracellular calcium release.
    Schaeffer P; Laplace MC; Savi P; Pflieger AM; Gully D; Herbert JM
    J Biol Chem; 1995 Feb; 270(7):3409-13. PubMed ID: 7852427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin induces the release of prostacyclin from human umbilical vein endothelial cells in vitro and increases plasma prostacyclin levels in the rat.
    Schaeffer P; Laplace MC; Prabonnaud V; Bernat A; Gully D; Lespy L; Herbert JM
    Eur J Pharmacol; 1997 Apr; 323(2-3):215-21. PubMed ID: 9128841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1).
    Akunne HC; Demattos SB; Whetzel SZ; Wustrow DJ; Davis DM; Wise LD; Cody WL; Pugsley TA; Heffner TG
    Biochem Pharmacol; 1995 Apr; 49(8):1147-54. PubMed ID: 7748196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
    Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
    Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of binding sites and efficacy of a species-specific peptide at rat and human neurotensin receptors.
    Cusack B; Chou T; Jansen K; McCormick DJ; Richelson E
    J Pept Res; 2000 Jan; 55(1):72-80. PubMed ID: 10667863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
    Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin receptors on the rat liver plasma membranes.
    Muraki K; Nishi Y; Arai M; Kubo N; Ueda K; Shikata H; Nakata Y; Segawa T; Yanaihara N; Yajima H
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1071-9. PubMed ID: 3038090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical vein endothelial cells express high affinity receptors for factor Xa.
    Bono F; Herault JP; Avril C; Schaeffer P; Lormeau JC; Herbert JM
    J Cell Physiol; 1997 Jul; 172(1):36-43. PubMed ID: 9207923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding chemistry and molecular heterogeneity of neurotensin binding protein(s)/receptor in adult chicken tissues.
    Mitra SP
    Indian J Biochem Biophys; 2013 Dec; 50(6):511-20. PubMed ID: 24772976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and biologic activity of neurotensin in guinea pig ileum.
    Carraway RE; Mitra SP
    Peptides; 1994; 15(8):1451-9. PubMed ID: 7700847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
    Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein.
    Bozou JC; Rochet N; Magnaldo I; Vincent JP; Kitabgi P
    Biochem J; 1989 Dec; 264(3):871-8. PubMed ID: 2559720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a biologically active fluorescent probe for labeling neurotensin receptors.
    Faure MP; Gaudreau P; Shaw I; Cashman NR; Beaudet A
    J Histochem Cytochem; 1994 Jun; 42(6):755-63. PubMed ID: 8189037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cyclic GMP levels by neurotensin in neuroblastoma clone N1E115.
    Amar S; Mazella J; Checler F; Kitabgi P; Vincent JP
    Biochem Biophys Res Commun; 1985 May; 129(1):117-25. PubMed ID: 2988544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
    Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.
    Sefler AM; He JX; Sawyer TK; Holub KE; Omecinsky DO; Reily MD; Thanabal V; Akunne HC; Cody WL
    J Med Chem; 1995 Jan; 38(2):249-57. PubMed ID: 7830267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and internalization of neurotensin in hybrid cells derived from septal cholinergic neurons.
    Faure MP; Labbé-Jullié C; Cashman N; Kitabgi P; Beaudet A
    Synapse; 1995 Jun; 20(2):106-16. PubMed ID: 7570339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors.
    Nouel D; Faure MP; St Pierre JA; Alonso R; Quirion R; Beaudet A
    J Neurosci; 1997 Mar; 17(5):1795-803. PubMed ID: 9030638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon.
    Azriel Y; Burcher E
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1074-81. PubMed ID: 11356931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
    Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
    J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.